sechenovSechenov Medical JournalСеченовский вестник2218-73322658-3348Сеченовский Университетsechenov-630Research ArticlePEDIATRICSПЕДИАТРИЯA modern view on diagnosis and treatment of the mucocutaneous lymphonodular syndrome (Kawasaki syndrome)Современный взгляд на диагностику и лечение слизисто-кожного лимфонодулярного синдрома (синдрома Кавасаки)ЛыскинаГ. А.LyskinaG. A.

Галина Афанасьевна Лыскина, д.м.н., профессор кафедры детских болезней

119001, г. Москва, ул. Б. Пироговская, д. 19

8 (499) 248–64–79

Galina Afanasievna Lyskina, MD, prof. of the chair of childhood diseases

19 B. Pirogovskaya str., Moscow, 119991

8 (499) 248–64–79

liskina@mma.ruШиринскаяО. Г.ShirinskayaO. G.

к.м.н., старший научный сотрудник НИО педиатрии НИЦ

PhD, senior researcher of the Department of researches in pediatrics of the Research Centre

Первый МГМУ им. И.М. СеченоваРоссияI.M. Sechenov First MSMURussian Federation201430032014018489Copyright © Lyskina G.A., Shirinskaya O.G., 20142014Лыскина Г.А., Ширинская О.Г.Lyskina G.A., Shirinskaya O.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sechenovmedj.com/jour/article/view/630

The article under review considers the problem of diagnostics and treatment of Kawasaki syndrome in children. The data of modern research, conclusions about the tactics and strategy of treating a disease are given and discussed.

В данной статье рассматривается проблема диагностики и лечения синдром Кавасаки у детей. Приведены данные современных исследований, сделаны выводы о тактике и стратегии лечения заболевания.

детские болезнисиндром Кавасакиклиническая диагностикаchildhood diseasesKawasaki syndromeclinical diagnosticsReferencesKawasaki T., Kosaki F., Okawa S. et al. A new infantile acute febrile mucocutaneous lymphnode syndrome (MLNS) prevailing in Japan. Pediatrics. 1974; 54: 271–276.Kawasaki T., Kosaki F., Okawa S. et al. A new infantile acute febrile mucocutaneous lymphnode syndrome (MLNS) prevailing in Japan. Pediatrics. 1974; 54: 271–276.Burns J.C. The riddle of Kawasaki disease. N. Engl. J. Med. 2007; 356: 659–661.Burns J.C. The riddle of Kawasaki disease. N. Engl. J. Med. 2007; 356: 659–661.Лыскина Г.А., Ширинская О.Г. Слизисто-кожный лимфонодулярный синдром (синдром Кавасаки). Диагностика и лечение. М.: «Видар-М». 2008.Lyskina G.A., Shirinskaya O.G. Mucocutaneous limfonodular syndrome (Kawasaki syndrome). Diagnosis and treatment. M.: «Vidar-M». 2008.Rowley A.H., Shulman S.T. Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther 2010;8:197-203.Rowley A.H., Shulman S.T. Pathogenesis and management of Kawasaki disease. Expert Rev Anti Infect Ther 2010;8:197-203.Лыскина Г.А., Виноградова О.И., Ширинская О.Г. Синдром Кавасаки в клинической практике: клиника и лечение дебюта заболевания / Под ред. Геппе Н.А. М.: «Планида», 2012. 36 с.Lyskina G.A., Vinigradova O.I., Shirinskaya O.G. Kawasaki syndrome in clinical practice: clinical features and treatment of onset of the disease. Ed. by Geppe N.A. M.: «Planida». 2012. 36 p.Лыскина Г.А., Ширинская О.Г. Клиническая картина, диагностика и лечение синдрома Кавасаки: известные факты и нерешенные проблемы // Вопросы современной педиатрии. 2013; 1(12): 63-73.Lyskina G.A., Shirinskaya O.G. The clinical picture, diagnosis and treatment of the syndrome Kawasaki: known facts and unsolved problems // Voprosy sovremennoj pediatrii. 2013; 1(12): 63-73.Baker A.L., Lu M., Minich L.L. et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J. Pediatr. 2009; 154: 592–595Baker A.L., Lu M., Minich L.L. et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J. Pediatr. 2009; 154: 592–595Oates-Whitehead RM, Baumer JH, Haines L, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003:CD004000.Oates-Whitehead RM, Baumer JH, Haines L, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003:CD004000.Newburger J.W., Takahashi M., Gerber M.A. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33.Newburger J.W., Takahashi M., Gerber M.A. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33.Sakata K., Hamaoka K., Ozawa S. et al. A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease. Eur. J. Pediatr. 2007; 166: 565–571.Sakata K., Hamaoka K., Ozawa S. et al. A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease. Eur. J. Pediatr. 2007; 166: 565–571.Лыскина Г.А., Ширинская О.Г., Виноградова О.И., Брегель Л.В., Субботин В.М., Бернс Дж. Клиника, диагностика и лечение синдрома Кавасаки. Рекомендации клинические. Разработаны Комитетом экспертов Всероссийской общественной организации Ассоциации детских кардиологов России, Департамента здравоохранения Москвы, сотрудниками Первого МГМУ им. И.М. Сеченова, Иркутской ГМАПО при участии сотрудников Научного центра по изучению болезни Кавасаки США. М., 2012. 55 с.Lyskina G.A., Shirinskaya O.G., Vinogradova O.I., Bregel L.V., Subbotin V.M., Burns J. Clinical features, diagnosis and treatment of Kawasaki syndrome. Clinical recommendations. Developed by the Committee of Experts-Russian Public Organization of Association of pediatric cardiologists of Russia, Moscow Department of Health, the staff of the First MSMU named after I.M. Sechenov, Irkutsk SMAPO involving employees of the Scientifi c Center for the Study of Kawasaki disease in United States. M. 2012. 55 p.Hsieh K.S., Weng K.P., Lin C.C., Huang T.C., Lee C.L., Huang S.M. Treatment of acute Kawasaki disease: aspirin’s role in the febrile stage revisited. Pediatrics. 2004; 114(6): 689–693.Hsieh K.S., Weng K.P., Lin C.C., Huang T.C., Lee C.L., Huang S.M. Treatment of acute Kawasaki disease: aspirin’s role in the febrile stage revisited. Pediatrics. 2004; 114(6): 689–693.Burns J.C., Mason W.H. Infl iximab treatment for refractory Kawasaki syndrome. The J. of Pediatr. 2005; 146: 662–667.Burns J.C., Mason W.H. Infl iximab treatment for refractory Kawasaki syndrome. The J. of Pediatr. 2005; 146: 662–667.Джейн Бернс. Методы лечения острой стадии болезни Кавасаки. Доктор Ру 2013; 9(87): 2-3.Jane Burns. Methods for the treatment of acute stage of Kawasaki disease. Doktor Ru. 2013; 9(87): 2-3.Furukawa T., Kishiro M., Akimoto K. et al. Eff ects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch. Dis. Child. 2008; 93: 142–146.Furukawa T., Kishiro M., Akimoto K. et al. Eff ects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch. Dis. Child. 2008; 93: 142–146.Orenstein J.M., Shulman S.T., Fox L.M., Baker S.C., Takahashi M., et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7: e3899, 2012.Orenstein J.M., Shulman S.T., Fox L.M., Baker S.C., Takahashi M., et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7: e3899, 2012.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008) — digest version. Circ. J.2010; 74: 1989–2020.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008) — digest version. Circ. J.2010; 74: 1989–2020.

The authors declare that there are no conflicts of interest present.